From working in the corporate world to nursing to advocacy
Publication date: Available online 11 May 2021Source: The Lancet HaematologyAuthor(s): Agnes Nsofwa (Source: The Lancet Haematology)
Source: The Lancet Haematology - May 13, 2021 Category: Hematology Source Type: research
COVID-19-associated coagulopathy and antithrombotic agents—lessons after 1 year
Publication date: Available online 27 April 2021Source: The Lancet HaematologyAuthor(s): Jenneke Leentjens, Thijs F van Haaps, Pieter F Wessels, Roger E G Schutgens, Saskia Middeldorp (Source: The Lancet Haematology)
Source: The Lancet Haematology - April 28, 2021 Category: Hematology Source Type: research
COVID-19 vaccines: building and maintaining confidence
Publication date: May 2021Source: The Lancet Haematology, Volume 8, Issue 5Author(s): The Lancet Haematology (Source: The Lancet Haematology)
Source: The Lancet Haematology - April 22, 2021 Category: Hematology Source Type: research
Sevuparin trial for acute pain in sickle cell disease: the dog that did not bark
Publication date: May 2021Source: The Lancet Haematology, Volume 8, Issue 5Author(s): Patrick Ellsworth, Jane A Little (Source: The Lancet Haematology)
Source: The Lancet Haematology - April 22, 2021 Category: Hematology Source Type: research
Surviving the storm: critical care outcomes of chimeric antigen receptor T-cell therapy
Publication date: May 2021Source: The Lancet Haematology, Volume 8, Issue 5Author(s): Janhavi Athale, Nirali N Shah (Source: The Lancet Haematology)
Source: The Lancet Haematology - April 22, 2021 Category: Hematology Source Type: research
Accurate accounting of caplacizumab cost effectiveness
Publication date: May 2021Source: The Lancet Haematology, Volume 8, Issue 5Author(s): George Goshua, Vinay Prasad, Alfred Ian Lee, Pavan K Bendapudi (Source: The Lancet Haematology)
Source: The Lancet Haematology - April 22, 2021 Category: Hematology Source Type: research
Accurate accounting of caplacizumab cost effectiveness – Authors' reply
Publication date: May 2021Source: The Lancet Haematology, Volume 8, Issue 5Author(s): Mary Hughes, Nicole Elliot, Amanda I Adler (Source: The Lancet Haematology)
Source: The Lancet Haematology - April 22, 2021 Category: Hematology Source Type: research
Sevuparin for the treatment of acute pain crisis in patients with sickle cell disease: a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial
Publication date: May 2021Source: The Lancet Haematology, Volume 8, Issue 5Author(s): Bart J Biemond, Anil Tombak, Yurdanur Kilinc, Murtadha Al-Khabori, Miguel Abboud, Mohammed Nafea, Adlette Inati, Yasser Wali, Jens Kristensen, Jan Kowalski, Ellen Donnelly, John Ohd, Erfan Nur, Anita W. Rijneveld, Alibülent Antmen, Marvin Reid, Gabriel Ukala, Lisa Kirven-Dawes, Curis Yeates, Hugh Wong (Source: The Lancet Haematology)
Source: The Lancet Haematology - April 22, 2021 Category: Hematology Source Type: research
Outcomes in patients treated with chimeric antigen receptor T-cell therapy who were admitted to intensive care (CARTTAS): an international, multicentre, observational cohort study
Publication date: May 2021Source: The Lancet Haematology, Volume 8, Issue 5Author(s): Élie Azoulay, Pedro Castro, Adel Maamar, Victoria Metaxa, Alice Gallo de Moraes, Louis Voigt, Florent Wallet, Kada Klouche, Muriel Picard, Anne-Sophie Moreau, Andry Van De Louw, Amélie Seguin, Djamel Mokart, Sanjay Chawla, Julien Leroy, Boris Böll, Nahema Issa, Bruno Levy, Pleun Hemelaar, Sara Fernandez (Source: The Lancet Haematology)
Source: The Lancet Haematology - April 22, 2021 Category: Hematology Source Type: research
Polyclonal hypergammaglobulinaemia: assessment, clinical interpretation, and management
Publication date: May 2021Source: The Lancet Haematology, Volume 8, Issue 5Author(s): Eric J Zhao, Catherine V Cheng, Andre Mattman, Luke Y C Chen (Source: The Lancet Haematology)
Source: The Lancet Haematology - April 22, 2021 Category: Hematology Source Type: research
The power of specialty palliative care: moving towards a systems perspective
Publication date: May 2021Source: The Lancet Haematology, Volume 8, Issue 5Author(s): Amber E Barnato, Inas S Khayal (Source: The Lancet Haematology)
Source: The Lancet Haematology - April 22, 2021 Category: Hematology Source Type: research
Ocular involvement in extranodal natural-killer T-cell lymphoma
Publication date: May 2021Source: The Lancet Haematology, Volume 8, Issue 5Author(s): Peizeng Yang, Zhenyu Zhong, Zi Ye, Jia Shu (Source: The Lancet Haematology)
Source: The Lancet Haematology - April 22, 2021 Category: Hematology Source Type: research
Response to first vaccination against SARS-CoV-2 in patients with multiple myeloma
Publication date: Available online 19 April 2021Source: The Lancet HaematologyAuthor(s): Sarah Bird, Aikaterini Panopoulou, Robyn L Shea, Micky Tsui, Radovan Saso, Amit Sud, Sharon West, Katy Smith, John Barwood, Ewa Kaczmarek, Carmela Panlaqui, Martin Kaiser, Simon Stern, Charlotte Pawlyn, Kevin Boyd (Source: The Lancet Haematology)
Source: The Lancet Haematology - April 20, 2021 Category: Hematology Source Type: research
Will the changing therapeutic landscape meet the needs of patients with sickle cell disease?
Publication date: Available online 7 April 2021Source: The Lancet HaematologyAuthor(s): Baba Psalm Duniya Inusa, Maddalena Casale, Andrew Campbell, Natasha Archer (Source: The Lancet Haematology)
Source: The Lancet Haematology - April 8, 2021 Category: Hematology Source Type: research
Voxelotor in adolescents and adults with sickle cell disease (HOPE): long-term follow-up results of an international, randomised, double-blind, placebo-controlled, phase 3 trial
Publication date: Available online 7 April 2021Source: The Lancet HaematologyAuthor(s): Jo Howard, Kenneth I Ataga, Robert C Brown, Maureen Achebe, Videlis Nduba, Amal El-Beshlawy, Hoda Hassab, Irene Agodoa, Margaret Tonda, Sarah Gray, Joshua Lehrer-Graiwer, Elliott Vichinsky (Source: The Lancet Haematology)
Source: The Lancet Haematology - April 8, 2021 Category: Hematology Source Type: research
